How effective is Modafinil for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 3.4/5 Long term ratings: 3.3/5
This is a phase IV clinical study of how effective Modafinil (modafinil) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 65 Modafinil users and is updated continuously.
What is Modafinil?
Modafinil has active ingredients of modafinil. It is often used in narcolepsy. eHealthMe is studying from 20,805 Modafinil users. Check the latest studies of Modafinil.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 609 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
65 people are studied for taking Modafinil in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Modafinil effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 2
- somewhat: 14
- moderate: 14
- high: 24
- very high: 11
Long Term:
- not at all: 1
- somewhat: 5
- moderate: 3
- high: 6
- very high: 3
Gender of people who take Modafinil for Attention deficit hyperactivity disorder *:
- female: 43.08 %
- male: 56.92 %
Age of people who take Modafinil for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 3.08 %
- 20-29: 36.92 %
- 30-39: 20.0 %
- 40-49: 21.54 %
- 50-59: 12.31 %
- 60+: 6.15 %
Who find Modafinil more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Modafinil for Attention deficit hyperactivity disorder *:
- female: 40 %
- male: 60 %
Age of people who take Modafinil for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.86 %
- 20-29: 40.0 %
- 30-39: 14.29 %
- 40-49: 22.86 %
- 50-59: 14.29 %
- 60+: 5.71 %
* Approximation only. Some reports may have incomplete information.
Do you take Modafinil?
- You can start a phase IV clinical trial to monitor Modafinil safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Modafinil (20,805 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,336 reports)
How the study uses the data?
The study is based on modafinil (the active ingredients of Modafinil) and Modafinil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dexamethasone Sodium Phosphate cause Vertigo Aggravated? - 5 seconds ago
- Could Casodex cause Tooth Abscess? - 11 seconds ago
- Could Simponi cause Restless Leg Syndrome? - 15 seconds ago
- Drug interactions of Ticar and Famciclovir - 16 seconds ago
- Could Tylenol cause Blood Potassium Decreased? - 33 seconds ago
- Drug interactions of Methotrexate and Msm - 37 seconds ago
- Could Lutein cause Laryngitis? - 42 seconds ago
- Could Vitamin B6 cause Obsessive-Compulsive Disorder? - 43 seconds ago
- Symbicort vs. Benzonatate, side effect and effectiveness comparison - 57 seconds ago
- Could Norvasc cause Anaemia Haemolytic Autoimmune? - a minute ago